Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis
- Conditions
- Prosthetic valve infective endocarditisTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
- Registration Number
- EUCTR2021-002898-26-FR
- Lead Sponsor
- CHU DE BORDEAUX
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 40
- Adult patient (over 18 years old);
- Patient with a prosthetic heart valve;
- Patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);
- Patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;
- Patient beneficiary of a social security scheme;
- Free, informed and written consent signed by the participant and the investigator.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10
- pregnant or breastfeeding women;
- women of childbearing potential not using effective contraception;
- patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent);
- subject in a period of relative exclusion due to another protocol;
- known contraindication to PET/CT with injection of radiotracers (hypersensitivity to radiopharmaceuticals and/or excipients).
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method